Linical Co

Linical Co Asset Growth

The Year-over-Year Total Asset Growth of Linical Co (2183.T) as of Nov 4, 2026 is -28.47 %. In the previous year, Year-over-Year Total Asset Growth was -9.52 % — a change of 199.10% (lower).

Asset Growth

-28.47 %

YoY

199.10%

Last updated:

Year-over-Year Total Asset Growth of Linical Co is 2026 -28.47 % . Year-over-Year Total Asset Growth of Linical Co was 2025 -9.52 % . It decreases by 199.10% lower compared to the previous year.

The Linical Co Asset Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Asset Growth
Date
Asset Growth
Jan 1, 2019
43.38 JPY
Jan 1, 2020
7.56 JPY
Jan 1, 2021
7.15 JPY
Jan 1, 2022
2.85 JPY
Jan 1, 2023
11.12 JPY
Jan 1, 2024
6.16 JPY
Jan 1, 2025
-9.52 JPY
Jan 1, 2026
-28.47 JPY
The Linical Co Asset Growth history
YEARAsset GrowthYoY
-28.47 %+199.10%
-9.52 %-254.59%
6.16 %-44.65%
11.12 %+289.99%
2.85 %-60.11%
7.15 %-5.36%
7.56 %-82.58%
43.38 %+280.12%
11.41 %-31.00%
16.54 %-36.94%
26.23 %-73.49%
98.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

Year-over-Year Total Asset Growth of Linical Co is -28.47 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Total Asset Growth Linical Co since 2006 – with annual values, charts, and detailed analysis.

Asset growth measures the percentage change in total assets. Rapid asset growth may indicate expansion but can also correlate with lower future returns.

To evaluate Year-over-Year Total Asset Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Total Asset Growth.

Year-over-Year Total Asset Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Total Asset Growth's Linical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Linical Co

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Linical Co